Friday
SESSION 31: PROGRESS IN THE TREATMENT OF VENOUS DISEASE – PART IA (5-MINUTE TALKS)
Moderators:Mark H. Meissner, MD / Lowell S. Kabnick, MD, FACS, FACPh  
SESSION 31 SCHEDULE
9:25 AM - 9:30 AM Current Treatment For Giant A-V Fistulas Of Renal And Visceral Vessels: Is Endovascular Treatment Feasible And How
  Presenter(s):Peter Gloviczki, MD  
9:31 AM - 9:36 AM Current Optimal Surgical Treatment Of Phlegmasia Cerulea Dolens
  Presenter(s):Kamphol Laohapensang, MD  
  View Abstract      
9:37 AM - 9:42 AM Incidence Of Upper Extremity DVT After Central Venous Catheter Placement: Implications And What To Do About It
  Presenter(s):Gregory L. Moneta, MD  
9:43 AM - 9:48 AM Superior Vena Cava Aneurysm: Natural History And Indications For Treatment
  Presenter(s):J. Leonel Villavicencio, MD  
9:49 AM - 9:54 AM Venous Aneurysms: What Are They And Are They Dangerous: Rupture Risk Has Been Exaggerated And Not All Need To Be Repaired
  Presenter(s):Jerry Goldstone, MD, FACS, FRCSEd  
  View Abstract      
9:55 AM - 10:00 AM Tips And Tricks For Iliac Vein And IVC Stenting: Access, Crossing Lesions, Stent Choice And Size
  Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS  
  View Abstract      
10:01 AM - 10:06 AM Current Status Of Stenting For Iliac Vein And Caval Disease: Indications, Which Stent Is Best, Precautions
  Presenter(s):Seshadri Raju, MD / Peter Neglen, MD, PhD  
  View Abstract      
10:07 AM - 10:12 AM Iliac Vein Stenting For Advanced Chronic Venous Disease: When Will It Improve Symptoms And When Will It Not: Is IVUS Essential
  Presenter(s):Anil P. Hingorani, MD / Enrico Ascher, MD  
  View Abstract      
10:13 AM - 10:18 AM Connecticut Experience With Wall Stenting For Iliac Vein Disease Under IVUS Control: Raju And Neglen Are Right
  Presenter(s):Paul J. Gagne, MD  
  View Abstract      
10:19 AM - 10:24 AM Is There Any Treatment Available For Patients Who Already Have Postthrombotic Syndrome?
  Presenter(s):Jose I. Almeida, MD, FACS, RVT  
10:25 AM - 10:35 AM Panel Discussion
END OF SESSION 31
previous next